Advisor Group’s Merck MRK Stock Holding History

Advisor Group’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-2	Closed	-$1K	–	5392
2019 Q3	$1K	Buy	+2	New	+$160	﹤0.01%	5134

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Advisor Group's MRK Position: Q4 2019 in Review

Advisor Group increased its Merck (MRK) stake by 4.5% in Q4 2019, buying an estimated $1.33M and bringing the position to 371,421 shares worth $32.2M. The position accounts for 0.22% of the portfolio, ranked #84.

Advisor Group first reported a position in MRK in Q2 2016 and has held it in 15 quarters since. 2,536 funds tracked by Wall St. Rank hold MRK as of Q4 2019.

Advisor Group held 371,421 shares of Merck worth $32.2M as of Q4 2019.
Advisor Group bought 16,147 Merck shares in Q4 2019, an estimated $1.33M.
Merck made up 0.22% of Advisor Group's portfolio in Q4 2019, its #84 holding.
Advisor Group first reported a position in Merck in Q2 2016 and has held it in 15 quarters since.
2,536 funds tracked by Wall St. Rank held Merck as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.